Agf Investments LLC Catalent, Inc. Transaction History

Agf Investments LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$101.51 - $125.27 $22,738 - $28,060	-224 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$85.88 - $105.36 $6,183 - $7,585	-72 Reduced 24.32%	224 $23,000
Q3 2020 Nov 12, 2020	SELL	$72.74 - $92.5 $2,909 - $3,700	-40 Reduced 11.9%	296 $25,000
Q2 2020 Aug 11, 2020	BUY	$48.02 - $79.04 $5,282 - $8,694	110 Added 48.67%	336 $25,000
Q1 2020 May 08, 2020	BUY	$36.95 - $62.95 $886 - $1,510	24 Added 11.88%	226 $12,000
Q4 2019 Feb 12, 2020	SELL	$47.06 - $56.64 $1,317 - $1,585	-28 Reduced 12.17%	202 $11,000
Q3 2019 Nov 12, 2019	BUY	$47.45 - $58.05 $10,913 - $13,351	230 New	230 $11,000
Q2 2018 Aug 13, 2018	SELL	$38.72 - $42.52 $1,664 - $1,828	-43 Closed	0 $0
Q1 2018 May 04, 2018	SELL	$39.4 - $47.39 $17,533 - $21,088	-445 Reduced 91.19%	43 $2,000
Q4 2017 Feb 07, 2018	BUY	$37.27 - $43.02 $819 - $946	22 Added 4.72%	488 $20,000
Q3 2017 Nov 09, 2017	BUY	$33.75 - $41.67 $15,727 - $19,418	466	466 $20,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Agf Investments LLC with notifications on news.